Developer docs
API playgroundTry for free, no card

Search company profiles

Chemular

Full company profile

uuid000ljjb

Namestring
Chemular
Legal namestring
Chemular International Inc.
Websiteurl
chemular.com
Company typeenum
Private
Founded yearint
2015
Descriptiontext

Chemular is a privately-held regulatory consulting firm founded in 2015 by industry and FDA veterans, headquartered in Hudson, Michigan (with corporate domicile in Ontario, Canada as Chemular International Inc.). The firm specializes in tobacco and nicotine regulatory compliance, providing a vertically-integrated suite of services including PMTA (Premarket Tobacco Product Application) preparation and FDA submission strategy, toxicological and clinical testing, product development, manufacturing solutions, and PACT Act / excise tax compliance for distributors and retailers. Chemular reports having supported PMTA submissions on 200+ products and operates a worldwide team of 35+ scientists, toxicologists, clinical trial experts, and regulatory project managers.

Its core technology stack combines traditional regulatory consulting with proprietary compliance infrastructure. Through its CMX (Chemular Market Xcellerator) offering the firm bundles product R&D, technology strategy, contract manufacturing, novel ingredients and IP licensing, and an AI-augmented capability branded 'Tobacco Titan AI.' Separately, Chemular co-founded IKE Tech LLC in February 2024 with Ispire Technology and Berify (Touchpoint World Wide), which has developed a blockchain-based, AI-powered age-gating platform for ENDS products including biometric verification, geo-fencing, and a patented 'Human Identity Token.' The JV received SOC 2 Type II certification, won dual 2026 Age Assurance Industry Awards, and its standalone PMTA for the age-gating technology was accepted by FDA in June 2025.

Chemular monetizes through professional services engagements (quote-based consulting for PMTA, regulatory strategy, and tax compliance), active-ingredients distribution via its North America Nicotine (NAN) subsidiary — described as North America's largest distributor of premium nicotine raw materials — and increasingly through licensing arrangements tied to the IKE Tech platform (e.g., the April 2026 Charlie's Holdings deal). Its customer base is concentrated in the tobacco and nicotine manufacturing vertical, with named enterprise clients including Glas Inc., Black Buffalo, Nic Nac Naturals, and White Fox. Go-to-market is sales-led direct engagement, supplemented by content marketing, TSRC/TPE/FDLI conference presence, and thought-leadership publications.

Short descriptiontext

Chemular is a private regulatory consulting firm serving tobacco and nicotine manufacturers with PMTA preparation, FDA submission strategy, toxicology testing, and PACT Act/excise tax compliance, supplemented by active-ingredients distribution and a blockchain-based age-gating JV (IKE Tech).

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersHudson, United States
HQ citystring
Hudson
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
regulatory consulting, tobacco compliance, PMTA submissions, nicotine product development, excise tax compliance
Industry4 codes
1Smoking Cessation & Nicotine Replacement Therapy (NRT)
CodeHLAIADAHPrimaryYes
2Nicotine Pouches (Tobacco-Free) Manufacturing & Brands
CodeCRADAJAIPrimaryNo
3E-liquids & Nicotine Salts Manufacturing & Brands
CodeCRADAJAGPrimaryNo
4Smokeless Tobacco (Chewing Tobacco, Snuff, Snus) Manufacturing & Brands
CodeCRADAJACPrimaryNo
NAICS code2 codes
  • Tobacco Product and Electronic Cigarette Merchant Wholesalers42494
  • Pharmaceutical and Medicine Manufacturing3254
SIC code2 codes
  • Tobacco Products2100
  • Pharmaceutical Preparations2834
Product category
Tobacco Regulatory Consulting
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Regulatory Consulting Services
TypeProfessional Services
Description

Professional consulting services for tobacco regulatory compliance, including PMTA preparation, FDA submissions, and regulatory strategy

chemular.com
2Active Ingredients Distribution
TypeHardware Sales
Description

Distribution of premium nicotine raw materials through North America Nicotine (NAN) subsidiary

chemular.com
3Tax Compliance Services
TypeProfessional Services
Description

PACT Act and excise tax compliance reporting services

chemular.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Supply Chain
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 3 records shown
1CMX
Description

Chemular Market Xcellerator offering full-range product development, regulatory strategy and manufacturing solutions

chemular.com
+2 more records
Core offering1 text field

Chemular is a regulatory consulting firm that helps tobacco and nicotine product manufacturers navigate FDA compliance, including Premarket Tobacco Product Application (PMTA) preparation and submission, regulatory strategy, and product development. The firm also distributes premium nicotine raw materials through its North America Nicotine affiliate and provides automated multi-state excise tax compliance services under a Compliance-as-a-Service model. Through the IKE Tech joint venture, Chemular co-develops blockchain-based biometric age-gating technology for ENDS products.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • First-ever FDA Marketing Granted Orders (MGOs) for flavored ENDS products incorporating Device Access Restriction technology
+1 more record
Product overview1 text field

Chemular is a worldwide regulatory consultancy specializing in tobacco and nicotine market segments. The company offers a vertically-integrated suite of regulatory and manufacturing solutions including Regulatory Consulting, Active Ingredients supply, Tax Compliance services, and the Chemular Market Xcellerator (CMX) for product development. Through a joint venture (IKE Tech LLC) with Ispire Technology Inc. and Berify, Chemular also offers proprietary age-gating technology for ENDS products using blockchain and biometric verification. CMX encompasses Product R&D, Technology Strategy, Contract Manufacturing, Novel Ingredients & Process, and Intellectual Property Licensing, with Tobacco Titan AI as an innovation capability.

Product and service5 records
1Regulatory Consulting
CategoryRegulatory Consulting
Description

Comprehensive regulatory consulting services for tobacco and nicotine product manufacturers, including Premarket Tobacco Product Application (PMTA) preparation, submission, and FDA compliance strategy. For manufacturers, brands, and distributors seeking FDA authorization.

2Active Ingredients (North America Nicotine)
CategoryActive Ingredients Distribution
Description

Supply chain and consulting for active ingredients in nicotine and tobacco products, distributed through the North America Nicotine affiliate. For nicotine product manufacturers and brands requiring premium raw material supply.

3Tax Compliance Services (Compliance as a Service / CaaS)
CategoryTax Compliance
Description

Automated multi-state excise tax compliance platform that tracks tax rates, calculates taxes, generates state-specific reports, and maintains audit-ready records. For tobacco distributors, retailers, and manufacturers with multi-state tax obligations and PACT Act reporting requirements.

4Chemular Market Xcellerator (CMX)
CategoryProduct Development and Manufacturing Solutions
Description

Integrated product development, regulatory strategy, and manufacturing solutions sub-brand bundling product R&D, technology strategy, contract manufacturing, novel ingredients and processes, and intellectual property licensing. For brands and manufacturers looking to launch products in the tobacco and nicotine market.

5IKE Tech Age-Gating Technology
CategoryAge-Gating and Compliance Technology
Description

Blockchain-based, AI-powered age-gating technology for ENDS products featuring biometric age verification, geo-fencing, real-time biometric identity platform, and patented Human Identity Token for user access control. Developed through the IKE Tech joint venture among Ispire Technology Inc., Berify, and Chemular Inc. For ENDS manufacturers seeking FDA-compliant youth-access prevention technology.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierFlagshipTypeTechnology or IntegrationAnnounced on2026-04-01
Description

Licensing agreement to commercialize IKE Tech's blockchain-based, continuous age-gated vape system in the U.S., including test marketing of the age-gated SBX disposable vape product.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-02-22
Description

Joint venture partnership to pioneer next-generation e-cigarette age-verification technology. Combines Ispire's hardware expertise with Chemular's regulatory consulting and PMTA know-how to develop and commercialize age-gating compliance solutions for the ENDS market.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-02-22
Description

Joint venture partnership leveraging Berify's multi-patented blockchain technology and digital engagement platform combined with Chemular's regulatory expertise to create age-verification solutions for vapor devices.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global testing, inspection, and certification giant with significant tobacco/nicotine testing operations (including Labstat). Comparable on the testing/lab-services side that Chemular provides to PMTA clients, though operates at vastly larger scale across many industries.

TypeBroad incumbent
Description

Medical device-focused CRO with regulatory consulting and testing capabilities. Comparable in regulatory science and testing services that overlap with Chemular's medical-device regulatory heritage, though broader in device than tobacco.

3Certeza Consulting
TypeEmerging player
Description

Boutique regulatory and quality consulting firm focused on FDA submissions and compliance for medical devices, pharma, and tobacco products. Smaller-scale but comparable boutique regulatory profile targeting PMTA-style submissions.

TypeBroad incumbent
Description

Large CRO offering preclinical safety, toxicology, and regulatory services across pharma and medical devices. Comparable toxicological and scientific testing depth that supports Chemular's PMTA work, though at much broader scale.

TypeBroad incumbent
Description

Large global CRO offering clinical, regulatory, and consulting services to pharma and medical device clients. Comparable regulatory consulting capabilities though much broader and larger scale; could potentially compete for tobacco-adjacent regulatory work.

TypeEmerging player
Description

Public vape hardware technology company and IKE Tech JV partner. Comparable in serving the ENDS regulatory and age-gating space; partner rather than competitor but operates in adjacent technology/compliance layer.

TypeDirect peer
Description

Tobacco-focused analytical testing and consulting firm (acquired by Eurofins) providing HPHC testing, product characterization, and PMTA-supporting scientific studies. Comparable to Chemular's HPHC, toxicological, and bioequivalence testing services for tobacco/nicotine clients.

TypeDirect peer
Description

UK-headquartered regulatory and scientific consultancy providing product chemistry, toxicology, and regulatory support to tobacco, e-cigarette, and pharmaceutical clients. Comparable niche consulting profile and tobacco/nicotine focus to Chemular.

TypeDirect peer
Description

U.S.-based consulting firm specializing in pharmaceutical, tobacco, and nicotine regulatory science, including PMTA support and risk assessment. Directly comparable service offering to Chemular's regulatory consulting arm.

TypeDirect peer
Description

Specialist regulatory consultancy providing medical device, IVD, and tobacco/nicotine regulatory services in the UK and EU. Highly comparable to Chemular given similar boutique regulatory focus, particularly in tobacco and nicotine product approvals.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Chemular

Tobacco Regulatory Consultingchemular.com

Chemular is a private regulatory consulting firm serving tobacco and nicotine manufacturers with PMTA preparation, FDA submission strategy, toxicology testing, and PACT Act/excise tax compliance, supplemented by active-ingredients distribution and a blockchain-based age-gating JV (IKE Tech).

What Chemular does

Chemular is a privately-held regulatory consulting firm founded in 2015 by industry and FDA veterans, headquartered in Hudson, Michigan (with corporate domicile in Ontario, Canada as Chemular International Inc.). The firm specializes in tobacco and nicotine regulatory compliance, providing a vertically-integrated suite of services including PMTA (Premarket Tobacco Product Application) preparation and FDA submission strategy, toxicological and clinical testing, product development, manufacturing solutions, and PACT Act / excise tax compliance for distributors and retailers. Chemular reports having supported PMTA submissions on 200+ products and operates a worldwide team of 35+ scientists, toxicologists, clinical trial experts, and regulatory project managers.

Its core technology stack combines traditional regulatory consulting with proprietary compliance infrastructure. Through its CMX (Chemular Market Xcellerator) offering the firm bundles product R&D, technology strategy, contract manufacturing, novel ingredients and IP licensing, and an AI-augmented capability branded 'Tobacco Titan AI.' Separately, Chemular co-founded IKE Tech LLC in February 2024 with Ispire Technology and Berify (Touchpoint World Wide), which has developed a blockchain-based, AI-powered age-gating platform for ENDS products including biometric verification, geo-fencing, and a patented 'Human Identity Token.' The JV received SOC 2 Type II certification, won dual 2026 Age Assurance Industry Awards, and its standalone PMTA for the age-gating technology was accepted by FDA in June 2025.

Chemular monetizes through professional services engagements (quote-based consulting for PMTA, regulatory strategy, and tax compliance), active-ingredients distribution via its North America Nicotine (NAN) subsidiary — described as North America's largest distributor of premium nicotine raw materials — and increasingly through licensing arrangements tied to the IKE Tech platform (e.g., the April 2026 Charlie's Holdings deal). Its customer base is concentrated in the tobacco and nicotine manufacturing vertical, with named enterprise clients including Glas Inc., Black Buffalo, Nic Nac Naturals, and White Fox. Go-to-market is sales-led direct engagement, supplemented by content marketing, TSRC/TPE/FDLI conference presence, and thought-leadership publications.

Chemular firmographics

Firmographics
Name
Chemular
Legal name
Chemular International Inc.
Website
https://chemular.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
11–50 employees
Short description
Chemular is a private regulatory consulting firm serving tobacco and nicotine manufacturers with PMTA preparation, FDA submission strategy, toxicology testing, and PACT Act/excise tax compliance, supplemented by active-ingredients distribution and a blockchain-based age-gating JV (IKE Tech).
Ownership category
akta.pro rank

Chemular industry classification

Industry
Product category
Tobacco Regulatory Consulting
NAICS
Tobacco Product and Electronic Cigarette Merchant Wholesalers (42494), Pharmaceutical and Medicine Manufacturing (3254)
SIC
Tobacco Products (2100), Pharmaceutical Preparations (2834)
akta.pro primary industry
Smoking Cessation & Nicotine Replacement Therapy (NRT) (HLAIADAH)
akta.pro secondary industries
Nicotine Pouches (Tobacco-Free) Manufacturing & Brands (CRADAJAI), E-liquids & Nicotine Salts Manufacturing & Brands (CRADAJAG), Smokeless Tobacco (Chewing Tobacco, Snuff, Snus) Manufacturing & Brands (CRADAJAC)

Keywords

  • Regulatory consulting
  • Tobacco compliance
  • PMTA submissions
  • Nicotine product development
  • Excise tax compliance

Where Chemular is headquartered

Location

Headquarters

HQ city
Hudson
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Chemular business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Supply Chain

Revenue model

  1. Regulatory Consulting Services: Professional consulting services for tobacco regulatory compliance, including PMTA preparation, FDA submissions, and regulatory strategy
  2. Active Ingredients Distribution: Distribution of premium nicotine raw materials through North America Nicotine (NAN) subsidiary
  3. Tax Compliance Services: PACT Act and excise tax compliance reporting services

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Chemular product offering

Product offering

Core offering

Chemular is a regulatory consulting firm that helps tobacco and nicotine product manufacturers navigate FDA compliance, including Premarket Tobacco Product Application (PMTA) preparation and submission, regulatory strategy, and product development. The firm also distributes premium nicotine raw materials through its North America Nicotine affiliate and provides automated multi-state excise tax compliance services under a Compliance-as-a-Service model. Through the IKE Tech joint venture, Chemular co-develops blockchain-based biometric age-gating technology for ENDS products.

Product overview

Chemular is a worldwide regulatory consultancy specializing in tobacco and nicotine market segments. The company offers a vertically-integrated suite of regulatory and manufacturing solutions including Regulatory Consulting, Active Ingredients supply, Tax Compliance services, and the Chemular Market Xcellerator (CMX) for product development. Through a joint venture (IKE Tech LLC) with Ispire Technology Inc. and Berify, Chemular also offers proprietary age-gating technology for ENDS products using blockchain and biometric verification. CMX encompasses Product R&D, Technology Strategy, Contract Manufacturing, Novel Ingredients & Process, and Intellectual Property Licensing, with Tobacco Titan AI as an innovation capability.

Differentiator

Problem solved

Functional benefit

Brands

  • CMX: Chemular Market Xcellerator offering full-range product development, regulatory strategy and manufacturing solutions
  • Tobacco Titan AI
  • IKE Tech LLC

Products and services

  • Regulatory Consulting Comprehensive regulatory consulting services for tobacco and nicotine product manufacturers, including Premarket Tobacco Product Application (PMTA) preparation, submission, and FDA compliance strategy. For manufacturers, brands, and distributors seeking FDA authorization.
  • Active Ingredients (North America Nicotine) Supply chain and consulting for active ingredients in nicotine and tobacco products, distributed through the North America Nicotine affiliate. For nicotine product manufacturers and brands requiring premium raw material supply.
  • Tax Compliance Services (Compliance as a Service / CaaS) Automated multi-state excise tax compliance platform that tracks tax rates, calculates taxes, generates state-specific reports, and maintains audit-ready records. For tobacco distributors, retailers, and manufacturers with multi-state tax obligations and PACT Act reporting requirements.
  • Chemular Market Xcellerator (CMX) Integrated product development, regulatory strategy, and manufacturing solutions sub-brand bundling product R&D, technology strategy, contract manufacturing, novel ingredients and processes, and intellectual property licensing. For brands and manufacturers looking to launch products in the tobacco and nicotine market.
  • IKE Tech Age-Gating Technology Blockchain-based, AI-powered age-gating technology for ENDS products featuring biometric age verification, geo-fencing, real-time biometric identity platform, and patented Human Identity Token for user access control. Developed through the IKE Tech joint venture among Ispire Technology Inc., Berify, and Chemular Inc. For ENDS manufacturers seeking FDA-compliant youth-access prevention technology.

Quantifiable outcome

  • First-ever FDA Marketing Granted Orders (MGOs) for flavored ENDS products incorporating Device Access Restriction technology
  • +1 more outcomes

Companies that use Chemular

Customer profile

Named customers4 records

Segments2 records

Ideal customer profiles2 records

Chemular technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature3 records

Chemular partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered flagship and core.

  • Charlie's HoldingsflagshipTechnology or Integration · 1 April 2026Licensing agreement to commercialize IKE Tech's blockchain-based, continuous age-gated vape system in the U.S., including test marketing of the age-gated SBX disposable vape product.
  • Ispire Technology Inc.coreStrategic or Co-development Partner · 22 February 2024Joint venture partnership to pioneer next-generation e-cigarette age-verification technology. Combines Ispire's hardware expertise with Chemular's regulatory consulting and PMTA know-how to develop and commercialize age-gating compliance solutions for the ENDS market.
  • Touchpoint World Wide Inc. (Berify)coreStrategic or Co-development Partner · 22 February 2024Joint venture partnership leveraging Berify's multi-patented blockchain technology and digital engagement platform combined with Chemular's regulatory expertise to create age-verification solutions for vapor devices.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Chemular competitors and assessment

Company assessment

Broad incumbents

  • Eurofins Scientific: Global testing, inspection, and certification giant with significant tobacco/nicotine testing operations (including Labstat). Comparable on the testing/lab-services side that Chemular provides to PMTA clients, though operates at vastly larger scale across many industries.
  • NAMSA: Medical device-focused CRO with regulatory consulting and testing capabilities. Comparable in regulatory science and testing services that overlap with Chemular's medical-device regulatory heritage, though broader in device than tobacco.
  • Charles River Laboratories: Large CRO offering preclinical safety, toxicology, and regulatory services across pharma and medical devices. Comparable toxicological and scientific testing depth that supports Chemular's PMTA work, though at much broader scale.
  • ICON plc: Large global CRO offering clinical, regulatory, and consulting services to pharma and medical device clients. Comparable regulatory consulting capabilities though much broader and larger scale; could potentially compete for tobacco-adjacent regulatory work.

Emerging players

  • Certeza Consulting: Boutique regulatory and quality consulting firm focused on FDA submissions and compliance for medical devices, pharma, and tobacco products. Smaller-scale but comparable boutique regulatory profile targeting PMTA-style submissions.
  • Ispire Technology Inc. Public vape hardware technology company and IKE Tech JV partner. Comparable in serving the ENDS regulatory and age-gating space; partner rather than competitor but operates in adjacent technology/compliance layer.

Direct peers

  • Labstat International (Eurofins): Tobacco-focused analytical testing and consulting firm (acquired by Eurofins) providing HPHC testing, product characterization, and PMTA-supporting scientific studies. Comparable to Chemular's HPHC, toxicological, and bioequivalence testing services for tobacco/nicotine clients.
  • Broughton Group: UK-headquartered regulatory and scientific consultancy providing product chemistry, toxicology, and regulatory support to tobacco, e-cigarette, and pharmaceutical clients. Comparable niche consulting profile and tobacco/nicotine focus to Chemular.
  • PinneyAssociates: U.S.-based consulting firm specializing in pharmaceutical, tobacco, and nicotine regulatory science, including PMTA support and risk assessment. Directly comparable service offering to Chemular's regulatory consulting arm.
  • Advena Limited: Specialist regulatory consultancy providing medical device, IVD, and tobacco/nicotine regulatory services in the UK and EU. Highly comparable to Chemular given similar boutique regulatory focus, particularly in tobacco and nicotine product approvals.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Chemular social profiles

Digital presence

Chemular compliance and trust

Trust signal

Compliance2 records

Chemular financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Chemular leadership team

Management profile

Number of profiles

Profiles1 record

Chemular funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Chemular M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Chemular

What does Chemular do?

Chemular is a regulatory consulting firm that helps tobacco and nicotine product manufacturers navigate FDA compliance, including Premarket Tobacco Product Application (PMTA) preparation and submission, regulatory strategy, and product development. The firm also distributes premium nicotine raw materials through its North America Nicotine affiliate and provides automated multi-state excise tax compliance services under a Compliance-as-a-Service model. Through the IKE Tech joint venture, Chemular co-develops blockchain-based biometric age-gating technology for ENDS products.

Is Chemular a public or private company?

Chemular is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Chemular founded?

Chemular was founded in 2015. It employs 11 to 50 people.

Where is Chemular based?

Chemular is headquartered in Hudson, United States, in the North America region.

How does Chemular make money?

Three revenue lines are on record. Regulatory Consulting Services are the primary driver. The others are active Ingredients Distribution and tax Compliance Services.

Who are Chemular's main competitors?

Broad incumbents on record are Eurofins Scientific, NAMSA, Charles River Laboratories and ICON plc. Emerging players are Certeza Consulting and Ispire Technology Inc.. Direct peers are Labstat International (Eurofins), Broughton Group, PinneyAssociates and Advena Limited.

Does Chemular have an API?

No public API is recorded for Chemular.

What industry is Chemular in?

Chemular's product category is Tobacco Regulatory Consulting. Its primary akta.pro industry code is HLAIADAH, Smoking Cessation & Nicotine Replacement Therapy (NRT), with a secondary code of CRADAJAI, Nicotine Pouches (Tobacco-Free) Manufacturing & Brands. Its NAICS code is 42494 and its SIC code is 2100.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Packaging GatewayChemular launches child-resistant packaging for nicotine pouchesRegulatory consulting group Chemular has launched Safeguard Mark I, a child-resistant packaging system designed to help nicotine pouch manufacturers comply with safety regulations without altering existing production equipment or FDA submissions. The platform functions as an external adapter that preserves brand visibility while reducing redevelopment costs and operational disruption for industry players.PR NewswireChemular Launches Safeguard™, A New Universal Approach to Child-Resistant Nicotine Pouch PackagingChemular launched Safeguard Mark I, a patent-pending child-resistant packaging platform for nicotine pouches. It integrates as an external component to existing cans, preserving branding and UPCs, and requires only a single application station. The company is now working with brands to evaluate the platform.PR NewswireIKETech Wins "Privacy-Centric Age Assurance Solution of the Year," Recognized for Innovation at Global Industry AwardsIKETech LLC, an AI-powered compliance infrastructure company and joint venture among Ispire Technology Inc., Berify, and Chemular Inc., received dual recognition at the Age Assurance Industry Awards 2026, winning "Privacy-Centric Age Assurance Solution of the Year" and being highly commended for "Innovation in Age Assurance Technology." The awards were presented at the Global Age Assurance Standards Summit in Manchester, UK, by an independent panel of experts spanning technology, policy, privacy, and youth protection. The recognition adds to the company's growing body of third-party validation including SOC 2 Type II certification and its FDA Premarket Tobacco Product Application submission.Stock TitanIspire JV presses FDA on ENDS compliance softwareIKE Tech LLC, a joint venture among Ispire Technology Inc., Berify, and Chemular Inc., participated in a formal listening session with the FDA's Center for Tobacco Products on April 9, 2026, presenting its point-of-use compliance technology designed to prevent youth usage of ENDS products, including biometric age-gating, blockchain-based product authentication, and an AI-powered governance backend. The company advocated for a regulatory framework recognizing compliance software as a tobacco product under the Tobacco Control Act, arguing that the current PMTA framework doesn't adequately address software-based systems with continuous updates and lifecycle management requirements. IKE Tech noted that its standalone component PMTA for the age-gating technology was accepted by the FDA in June 2025, with a Human Factors Validation Study demonstrating 100% effectiveness in preventing underage device activation.PR NewswireIspire Technology Inc. Reports Fiscal Third Quarter 2024 Financial ResultsIspire Technology Inc. reported fiscal Q3 2024 results with revenue up 24% year-over-year to $30.0 million and gross profit up 35% to $6.1 million, driven by a 57% increase in North American cannabis vaping hardware revenue to $11.9 million. The company posted a net loss of $5.9 million, more than double the $2.3 million loss in the same period of 2023, while operating expenses rose 64% to $11.8 million. Ispire also announced entering a joint venture with Berify and Chemular and closed a $12.3 million public offering to fund operations and its Malaysian manufacturing facility.PR NewswireIspire Technology Announces Pricing of $12.3 Million Public OfferingIspire Technology Inc. has priced a public offering of 2,050,000 shares at $6.00 per share, raising gross proceeds of $12.3 million. The company intends to use the net proceeds to establish a manufacturing facility in Malaysia and fund a joint venture with Touch Point Worldwide Inc. and Chemular Inc., alongside working capital needs. The offering is expected to close around March 26, 2024, following regulatory approval from the SEC.PR NewswireSesh+ Patented Nicotine Pouches' Premarket Tobacco Product Application (PMTA) Accepted for Review by FDASesh Products US, Inc. announced that its Premarket Tobacco Product Applications covering 72 Sesh+ nicotine pouch SKUs have been accepted for review by the U.S. FDA, marking progression to the next phase of the regulatory review process. The company submitted these applications in compliance with the May 2022 deadline for then-marketed synthetic nicotine products, with assistance from regulatory consulting firm Chemular Inc. Sesh positions its nicotine pouches as potentially less harmful alternatives for adult (21+) users who cannot or choose not to quit nicotine, with a stated goal of eliminating tobacco-related harm.